Advancing stem cell technologies for conservation of wildlife biodiversity.

Animals Biodiversity Conservation of Natural Resources / methods Animals, Wild Stem Cells / cytology Humans
In vitro gametogenesis Biodiversity Conservation Disease modelling IPSC Stem cells

Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
15 Oct 2024
Historique:
medline: 9 10 2024
pubmed: 9 10 2024
entrez: 9 10 2024
Statut: ppublish

Résumé

Wildlife biodiversity is essential for healthy, resilient and sustainable ecosystems. For biologists, this diversity also represents a treasure trove of genetic, molecular and developmental mechanisms that deepen our understanding of the origins and rules of life. However, the rapid decline in biodiversity reported recently foreshadows a potentially catastrophic collapse of many important ecosystems and the associated irreversible loss of many forms of life on our planet. Immediate action by conservationists of all stripes is required to avert this disaster. In this Spotlight, we draw together insights and proposals discussed at a recent workshop hosted by Revive & Restore, which gathered experts to discuss how stem cell technologies can support traditional conservation techniques and help protect animal biodiversity. We discuss reprogramming, in vitro gametogenesis, disease modelling and embryo modelling, and we highlight the prospects for leveraging stem cell technologies beyond mammalian species.

Identifiants

DOI: 10.1242/dev.203116 PMID: 39382939
pubmed: 39382939
pii: 362292
doi: 10.1242/dev.203116
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : University of Cambridge

Informations de copyright

© 2024. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests A.M.H. is program manager at Revive and Restore; R.B. is an Associate Director at Conception; S.C. is CEO of Brightfield Therapeutics; A.N. is a co-founder and Chief Scientific Officer of and has equity in GC Therapeutics; S.O. is Director of Species Restoration at Colossal Laboratories and Biosciences; A.J.P. is a Species-lead for Colossal Laboratories and Biosciences.; R.P. is executive director and co-founder of Revive and Restore; G.S. is CSO and co-founder at Occam Biosciences; T.N.K. is a contract employee for Colossal Laboratories and Biosciences.

Auteurs

Ashlee M Hutchinson (AM)

Revive & Restore, 1505 Bridgeway, Suite 203, Sausalito, CA 94965, USA.

Ruth Appeltant (R)

Gamete Research Centre, Veterinary Physiology and Biochemistry, Department of Veterinary Sciences, University of Antwerp, 2610 Wilrijk, Belgium.

Tom Burdon (T)

The Roslin Institute, RDSVS, University of Edinburgh, Easter Bush Campus, Midlothian EH25 9RG, UK.

Qiuye Bao (Q)

IMCB-ESCAR, A*STAR, 61 Biopolis Drive, Proteos, 138673Singapore.

Rhishikesh Bargaje (R)

Conception Bioscience, Berkeley, CA 94710, USA.

Andrea Bodnar (A)

Gloucester Marine Genomics Institute, 417 Main St, Gloucester, MA 01930, USA.

Stuart Chambers (S)

Brightfield Therapeutics, South San Francisco, CA 94080, USA.

Pierre Comizzoli (P)

Smithsonian National Zoo and Conservation Biology Institute, 3001 Connecticut Ave., NW Washington, DC 20008, USA.

Laura Cook (L)

Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA 94720, USA.
ORCID: 0000-0002-4459-2592

Yoshinori Endo (Y)

University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093, USA.

Bob Harman (B)

Vet-Stem Inc. & Personalized Stem Cells, Inc., 14261 Danielson Street, Poway, CA 92064, USA.

Katsuhiko Hayashi (K)

Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

Thomas Hildebrandt (T)

Leibniz Institute for Zoo and Wildlife Research, Alfred-Kowalke-Straße 17, 10315 Berlin, Germany.

Marisa L Korody (ML)

San Diego Zoo Wildlife Alliance, 2920 Zoo Dr, San Diego, CA 92101, USA.

Uma Lakshmipathy (U)

Thermo Fisher Scientific, 168 Third Avenue, Waltham, MA 02451, USA.

Jeanne F Loring (JF)

The Scripps Research Institute, 10550 N Torrey Pines Rd, La Jolla, CA 92037, USA.

Clara Munger (C)

Department of Biochemistry, University of Cambridge, Hopkins Building, Downing Site, Tennis Court Road, Cambridge CB2 1QW, UK.

Alex H M Ng (AHM)

GC Therapeutics, 610 Main St., North Cambridge, MA 02139, USA.

Ben Novak (B)

Revive & Restore, 1505 Bridgeway, Suite 203, Sausalito, CA 94965, USA.

Manabu Onuma (M)

National Institute for Environmental Studies, 16-2 Onogawa, City of Tsukuba, Ibaraki 305-8506, Japan.

Sara Ord (S)

Colossal Biosciences, 1401 Lavaca St, Unit #155 Austin, TX 78701, USA.

Monique Paris (M)

IBREAM (Institute for Breeding Rare and Endangered African Mammals), Edinburgh EH3 6AT, UK.

Andrew J Pask (AJ)

University of Melbourne, Parkville, VIC 3052, Australia.
ORCID: 0000-0002-1900-2263

Francisco Pelegri (F)

University of Wisconsin-Madison, 500 Lincoln Dr, Madison, WI 53706, USA.

Martin Pera (M)

Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.

Ryan Phelan (R)

Revive & Restore, 1505 Bridgeway, Suite 203, Sausalito, CA 94965, USA.

Benyamin Rosental (B)

The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Center for Regenerative Medicine and Stem Cells, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.

Oliver A Ryder (OA)

San Diego Zoo Wildlife Alliance, 2920 Zoo Dr, San Diego, CA 92101, USA.

Woranop Sukparangsi (W)

Department of Biology, Faculty of Science, Burapha University, 169 Long-Had Bangsaen Rd, Saen Suk, Chon Buri District, Chon Buri 20131, Thailand.

Gareth Sullivan (G)

Department of Pediatric Research, Oslo University Hospital, P.O. Box 4950 Nydalen, N-0424 Oslo, Norway.
School of Medicine, University of St Andrews, North Haugh, St Andrews KY16 9TF, UK.

Nicole Liling Tay (NL)

IMCB-ESCAR, A*STAR, 61 Biopolis Drive, Proteos, 138673Singapore.

Nikki Traylor-Knowles (N)

Rosenstiel School of Marine, Atmospheric, and Earth Science, University of Miami,4600, Rickenbacker Cswy, Key Biscayne, FL 33149, USA.

Shawn Walker (S)

ViaGen Pets & Equine, PO Box 1119, Cedar Park, TX 78613, USA.

Antonia Weberling (A)

All Souls College, University of Oxford, Oxford OX1 4AL, UK.

Deanne J Whitworth (DJ)

University of Queensland, Sir Fred Schonell Drive, Brisbane, Queensland, 4072, Australia.

Suzannah A Williams (SA)

University of Oxford, Oxford OX1 2JD, UK.

Jessye Wojtusik (J)

Omaha's Henry Doorly Zoo & Aquarium, 3701 S 10th St, Omaha, NE 68107, USA.

Jun Wu (J)

University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.

Qi-Long Ying (QL)

Keck School of Medicine of University of Southern California, 1975 Zonal Ave, Los Angeles, CA 90033, USA.

Thomas P Zwaka (TP)

Department of Cell, Developmental, and Regenerative Biology, and Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Timo N Kohler (TN)

Department of Biochemistry, University of Cambridge, Hopkins Building, Downing Site, Tennis Court Road, Cambridge CB2 1QW, UK.
ORCID: 0000-0003-1949-0655

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Advancing stem cell technologies for...
questionsmedicales.fr › Environnement et santé publique › Environnement › Écosystème › Biodiversité › Advancing stem cell technologies for...
questionsmedicales.fr › Environnement et santé publique › Environnement › Conservation des ressources naturelles › Advancing stem cell technologies for...
questionsmedicales.fr › Eucaryotes › Animaux › Groupes animaux › Animaux sauvages › Advancing stem cell technologies for...
questionsmedicales.fr › Cellules › Cellules souches › Advancing stem cell technologies for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Advancing stem cell technologies for...